Corcept Therapeutics Incorporated (NASDAQ:CORT) said on Thursday that it presented results from its Phase 2 DAZALS study of ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

Prescribed use of anti-anxiety drugs, hypnotics and sedatives, or antidepressants was tied to a higher future risk of ...

UC Irvine researchers conducted a study to better understand the molecular basis of amyotrophic lateral sclerosis (ALS), a ...

Brainstorm tapped Minaris to manufacture NurOwn for its upcoming Phase 3b clinical trial testing the treatment for ALS.

The donation will establish the Lois Pope Neuroscience Research Fund and will add Lorraine's name to the Lois Pope Laboratory ...

Amylyx Pharmaceuticals ( NASDAQ: AMLX) said on Tuesday that the U.S. FDA has granted fast track status to its antisense RNA, ...

Despite its growing role in tracking MS activity, serum neurofilament light chain lacks diagnostic specificity, experts say.

UC Irvine researchers conducted a study to better understand the molecular basis of amyotrophic lateral sclerosis (ALS), a ...

The Everylife Foundation for Rare Diseases is offering a new scholarship for U.S. students from the ALS community facing ...

Monday marked the annual Lou Gehrig Day, which took place on June 1-2 this year and raises awareness about ALS (Amyotrophic ...

As the global population ages, the risk of developing neurodegenerative diseases such as dementia, Alzheimer's disease, ...